MELISSA A MYERS
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry CONWAY, NH NPI 1689794604
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry NH E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$752.22
- Category: General Payments
- Program years: PY2018–2024
- Record count: 39
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $170.63 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $170.63 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $45.05 | 2 |
| Alkermes, Inc. | $35.72 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.03 | 1 |
| Teva Pharmaceuticals USA, Inc. | $22.51 | 1 |
| Janssen Pharmaceuticals, Inc | $18.27 | 1 |
| ABBVIE INC. | $15.05 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078086722 | Janssen Pharmaceuticals, Inc | $18.27 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101796347 | E.R. Squibb & Sons, L.L.C. | $24.63 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101796361 | E.R. Squibb & Sons, L.L.C. | $20.42 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105089895 | ABBVIE INC. | $15.05 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120560698 | Alkermes, Inc. | $15.46 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120560700 | Alkermes, Inc. | $20.26 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137640290 | Takeda Pharmaceuticals U.S.A., Inc. | $34.03 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151601827 | Teva Pharmaceuticals USA, Inc. | $22.51 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.